Witzeman Michael D 4
4 · CHEMED CORP · Filed Oct 22, 2025
Insider Transaction Report
Form 4
CHEMED CORPCHE
Witzeman Michael D
VP & Chief Financial Officer
Transactions
- Award
Stock Option (right to buy with tandem tax withholding)
2025-10-21$443.79/sh+19,486$8,647,692→ 53,970 totalExercise: $443.79Exp: 2030-10-21→ Capital Stock (19,486 underlying)
Footnotes (1)
- [F1]Vesting in three equal annual installments commencing 10/21/2026